Skip to content

An Integrated Treatment for Comorbid PTSD and Substance Abuse in Adolescents

An Integrated Treatment for Comorbid PTSD and Substance Abuse in Adolescents

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01825694
Enrollment
117
Registered
2013-04-08
Start date
2013-04-30
Completion date
2015-05-31
Last updated
2023-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Abuse, Traumatic Stress

Keywords

Substance Abuse, Traumatic Stress

Brief summary

This study plans to develop an integrated treatment for comorbid post-traumatic stress disorder (PTSD) and substance abuse (SA) in adolescents. The investigators aim to develop a treatment approach that is community-friendly, well-tolerated, and deliverable by substance abuse counselors (SAC) in outpatient settings. The proposed Trauma-Focused Substance Abuse Treatment (TFSAT) aims to reduce PTSD symptoms and substance use and build coping skills. The investigators propose to adapt an evidence-based trauma program, Cognitive-Behavioral Intervention for Trauma in Schools (CBITS), for adolescent substance abusers (ASAbusers); to assess the acceptability and feasibility of the integrated approach; and to pilot test the new program against standard care. The investigators hypothesize that the intervention group, compared to the control group, will reduce substance use and symptoms for traumatic stress.

Interventions

BEHAVIORALTrauma-focused Substance Abuse Intervention

An integrated treatment approach to reduce substance use and PTSD symptoms. The intervention program includes: 1) 1-2 individual sessions during which youth talk about the trauma, during the course of the intervention program; 2) 16 group sessions for youth; 3) 2 conjoint sessions with parents to improve communication and problem-solving skills; and 4) 2 parent-education group sessions.

Sponsors

University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to 19 Years
Healthy volunteers
No

Inclusion criteria

Youth * Between ages of 13 & 19; * meeting DSM IV criteria for substance abuse/dependence and PTSD; * previously enrolled at recruitment site for at least 2 weeks; * parent/guardian provides permission for minors to participate.

Exclusion criteria

Youth * Not within the specified age range; * presence of organic brain damage; * inability to understand enrollment forms (e.g. Informed Assent/Consent Form) Inclusion Criteria: Parents/Guardians * Age 18 or above; * parents/guardians of youth who meets inclusion criteria.

Design outcomes

Primary

MeasureTime frameDescription
Timeline Follow-back (TFLB) Assessment of Substance UseParticipants will be followed for an expected average of 12 weeks.The TLFB uses a blank calendar form and a series of questions to cue recall of alcohol and drug (AOD) use. The investigators will use the TLFB interview technique to assess AOD use weekly.
Urine Toxicology Screen (UTS)Participants will be followed for an expected average of 12 weeks.Urine samples will be collected twice per week at the treatment site to ensure validity of self-reports.
Child PTSD Symptom Scale (CPSS)Change from Baseline in Child PTSD Symptom Scale at 8 weeks and change from Baseline in Child PTSD Symptom Scale at 12 weeks.The CPSS will assess for severity of traumatic stress symptoms.

Secondary

MeasureTime frameDescription
Child Post-Trauma Attitudes Scale (C-PTAS)Baseline & 8 weeks & 3 monthsThe C-PTAS will be used to assess trauma-related attitudes and beliefs.
Strengths & Difficulties Questionnaire (SDQ)Baseline & 8 weeks & 3 monthsThe SDQ will be used to assess parent-report of behavioral problems.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026